Omland A K, Fedorcsák P, Storeng R, Dale P O, Abyholm T, Tanbo T
Department of Obstetrics and Gynaecology, National Hospital, University of Oslo, Oslo, Norway.
Hum Reprod. 2001 Dec;16(12):2587-92. doi: 10.1093/humrep/16.12.2587.
To elucidate possible differences between unexplained and minimal peritoneal endometriosis-associated infertility, we studied their outcome in natural cycle IVF (NIVF).
A prospective cohort study was carried out on unexplained (33 couples), minimal peritoneal endometriosis-associated (30 couples) and tubal factor (24 couples) infertility in 223 NIVF cycles, using human chorionic gonadotrophin (HCG) for ovulation induction.
During the first NIVF attempt, follicular and luteal phase oestradiol, FSH, LH and progesterone concentrations, as well as endometrial thickness and follicular diameter were similar among the three groups. Periovulatory follicular growth monitored from day of HCG administration to oocyte aspiration was significantly lowered in unexplained infertility compared with minimal endometriosis-associated and tubal factor infertility. The fertilization rate, clinical pregnancy rate per initiated cycle, per successful oocyte retrieval and per embryo transfer, in minimal endometriosis (80.0, 10.4, 16.0 and 23.5% respectively) were similar to that in tubal factor infertility patients (68.6, 5.8, 11.4 and 16.0%) but significantly higher (P < 0.05) than that of the unexplained infertility group (62.2, 2.6, 5.4 and 8.7%).
The significant reduction in follicular periovulatory growth, fertilization and pregnancy rates in unexplained infertility compared with minimal peritoneal endometriosis patients may be explained by sub-optimal follicular development with possibly reduced oocyte quality, intrinsic embryo quality factors or by impaired implantation. From a clinical point of view, NIVF is less suited to unexplained infertility treatment, but might represent an interesting treatment option for minimal peritoneal endometriosis-associated infertility.
为阐明不明原因性不孕与轻度腹膜子宫内膜异位症相关性不孕之间可能存在的差异,我们研究了它们在自然周期体外受精(NIVF)中的结局。
对223个NIVF周期中的不明原因性不孕(33对夫妇)、轻度腹膜子宫内膜异位症相关性不孕(30对夫妇)和输卵管因素性不孕(24对夫妇)进行了一项前瞻性队列研究,使用人绒毛膜促性腺激素(HCG)诱导排卵。
在首次NIVF尝试期间,三组之间的卵泡期和黄体期雌二醇、促卵泡激素(FSH)、促黄体生成素(LH)和孕酮浓度,以及子宫内膜厚度和卵泡直径相似。与轻度子宫内膜异位症相关性不孕和输卵管因素性不孕相比,不明原因性不孕中从注射HCG日至卵母细胞抽吸期间监测的围排卵期卵泡生长显著降低。轻度子宫内膜异位症患者的受精率、每个启动周期、每次成功取卵和每次胚胎移植后的临床妊娠率(分别为80.0%、10.4%、16.0%和23.5%)与输卵管因素性不孕患者(68.6%、5.8%、11.4%和16.0%)相似,但显著高于(P<0.05)不明原因性不孕组(62.2%、2.6%、5.4%和8.7%)。
与轻度腹膜子宫内膜异位症患者相比,不明原因性不孕患者围排卵期卵泡生长、受精率和妊娠率显著降低,可能是由于卵泡发育欠佳,卵母细胞质量可能降低、胚胎内在质量因素或着床受损所致。从临床角度来看,NIVF不太适合治疗不明原因性不孕,但可能是轻度腹膜子宫内膜异位症相关性不孕的一种有意义的治疗选择。